LONDON--(BUSINESS WIRE)--The global stroke therapeutics market size is poised to reach USD 1.37 billion by 2023, according to a new report by Technavio, progressing at a CAGR of close to 5% during the forecast period.
“Apart from the high-risk factors for stroke, the development of novel therapies, increasing awareness about stroke, and strategic alliances are some of the other major aspects expected to boost market growth during the forecast period,” says a senior analyst at Technavio. Request Free Sample Pages
The market is driven by high-risk factors for stroke. In addition, growth of geriatric population is anticipated to further boost the stroke therapeutics market during the forecast period.
Stroke is the second-leading cause of death globally among adults. The increase in risk factors such as high blood pressure, high cholesterol levels, heart diseases, diabetes, and smoking are considered to be the major drivers for the growth of the market.
Furthermore, the growth of the geriatric population is contributing to the occurrence of strokes globally. Increase in age leads to frailty and higher risk of comorbidities, which has a major impact on the tolerance to intensive treatment modalities. Therefore, the rise in the geriatric population is expected to increase the incidence a stroke which in turn will drive market expansion during the forecast period.
For More Information: Request Free Sample Pages
The report includes detailed profiles of the leading companies & prominent vendors of the market:
- Amgen Inc.
- AstraZeneca Plc
- Bayer AG
- Boehringer Ingelheim International GmbH
- Bristol-Myers Squibb Co.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Merck & Co. Inc.
- Pfizer Inc.
Market Segmentation by Category and Product Types:
The stroke therapeutics market can be broadly categorized into the following:
- Ischemic stroke
- Hemorrhagic stroke
Key Regions for the Stroke Therapeutics Market:
Featuring a breakdown of region-wise market shares until 2019.
- North America
Some of the key topics covered in the report include:
- Market ecosystem
- Market characteristics
Market segmentation analysis
- Market definition
Market size and forecast
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Related Reports on Health Care Market are:
Non-invasive Glucose Monitoring Devices Market – Global Non-invasive Glucose Monitoring Devices Market by product (wearable devices and non-wearable devices) and geography (Asia, Europe, North America, and ROW).
Gene Amplification Technologies Market– Global Gene Amplification Technologies Market by application (medical and pharmaceutical, forensic and identity testing, agricultural and food safety, and others) and geography (Asia, Europe, North America, and ROW).
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.